REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail tested for Tough-to-Treat blood cancers
Disease control OngoingThis early-stage study is testing the safety and best dose of a drug called palbociclib, given alone and in combination with other medications, for adults with acute leukemia that has come back or hasn't responded to previous treatments. The main goal is to find out what side eff…
Matched conditions: REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug combo aims to control Tough-to-Treat blood cancer
Disease control OngoingThis study is testing a multi-step treatment plan for adults with a specific, aggressive form of leukemia (ALL) that has come back or hasn't responded to prior therapy. The plan combines lower-intensity chemotherapy with two targeted drugs, ponatinib and blinatumomab, to attack t…
Matched conditions: REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for kids battling leukemia that Won't stay away
Disease control OngoingThis study is testing a new combination of two drugs, venetoclax and navitoclax, for children and young adults whose acute lymphoblastic leukemia has come back or hasn't responded to previous treatments. The main goals are to see if this combination can effectively clear the canc…
Matched conditions: REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for seniors battling aggressive blood cancer
Disease control OngoingThis study is testing two different treatment plans for adults aged 65 and older with a type of blood cancer called acute lymphoblastic leukemia (ALL). One plan combines an immunotherapy drug (blinatumomab) with standard chemotherapy. The other plan combines a targeted drug (dasa…
Matched conditions: REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Engineered immune cells unleashed to battle tough leukemia
Disease control OngoingThis early-stage study is testing a new type of cell therapy for adults with a high-risk or returning form of acute lymphoblastic leukemia (ALL). Doctors take a patient's own immune cells, modify them in a lab to better target cancer, and infuse them back after a short course of …
Matched conditions: REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Supercharged immune cells take aim at untreatable leukemia
Disease control OngoingThis early-stage study is testing the safety of a new type of personalized cell therapy for adults with acute lymphoblastic leukemia that has returned or hasn't responded to standard chemotherapy. Doctors collect a patient's own immune cells, genetically modify them to recognize …
Matched conditions: REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New hope for babies with aggressive leukemia: targeted drug trial underway
Disease control OngoingThis study is testing whether adding a new oral drug called revumenib to standard chemotherapy is safe and effective for infants and young children with a specific, high-risk type of leukemia that has come back or hasn't responded to previous treatments. The trial aims to find th…
Matched conditions: REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC